Business Context and Reporting Period
This Form 8-K, dated August 11, 2020, reports on ARYA Sciences Acquisition Corp III, a Cayman Islands-based special purpose acquisition company (SPAC). The filing details the consummation of its initial public offering (IPO) and a concurrent private placement. The company is classified as an emerging growth company.
Key Financial Metrics
- Capital Raised: The IPO consisted of 14,950,000 Class A ordinary shares at $10.00 per share, including the full exercise of the underwriters' over-allotment option.
- Private Placement: 499,000 Class A ordinary shares were sold to ARYA Sciences Holdings III.
- Trust Account: Aggregate proceeds of $149,500,000 from the IPO and private placement were deposited into a trust account with Continental Stock Transfer & Trust Company.
- Liquidity: Funds in the trust are restricted and cannot be released to the company until the completion of an initial business combination, except for interest earnings used to pay income taxes.
- Revenue and Profit: The filing text does not provide revenue, profit, or operating margin data as the company is a pre-business combination SPAC.
Material Changes
The primary material change is the transition from a private entity to a public company following the IPO closing on August 11, 2020. This event established the trust account holding $149.5 million, which serves as the primary liquidity source for future business combinations or shareholder redemptions.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The company must complete an initial business combination within 24 months from the closing of the IPO.
- Redemption Rights: Public shareholders have the right to redeem their shares for a pro-rata portion of the trust account if the company fails to complete a business combination within the 24-month period or in connection with specific amendments to the charter.
- Use of Proceeds: Proceeds are strictly held in trust and cannot be used for general corporate purposes until a business combination is consummated.
Investor Verification Checklist
- Verify the audited balance sheet included as Exhibit 99.1 to confirm the exact cash position in the trust account.
- Confirm the specific terms of the over-allotment option exercise and the total number of shares outstanding.
- Review the amended and restated memorandum and articles of association for detailed redemption limitations and amendment procedures.
- Monitor the 24-month timeline for the initial business combination to assess potential liquidation risks.